Wockhardt, a multinational pharmaceutical firm , has witnessed significant developments recently . This focus has turned to its ongoing turnaround efforts, notably following regulatory setbacks from multiple agencies. Importantly, the takeover of business units from its European facilities remains to be a key element in its plan for upcoming growth